See more : Aplisens S.A. (APN.WA) Income Statement Analysis – Financial Results
Complete financial analysis of Medicalgorithmics S.A. (MDG.WA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medicalgorithmics S.A., a leading company in the Medical – Devices industry within the Healthcare sector.
- Shandong Lubei Chemical Co., Ltd. (600727.SS) Income Statement Analysis – Financial Results
- Idaho Champion Gold Mines Canada Inc. (ITKO.CN) Income Statement Analysis – Financial Results
- Ross Group Plc (RGP.L) Income Statement Analysis – Financial Results
- Chun Zu Machinery Industry Co., Ltd. (4544.TWO) Income Statement Analysis – Financial Results
- American Nortel Communications, Inc. (ARTM) Income Statement Analysis – Financial Results
Medicalgorithmics S.A. (MDG.WA)
About Medicalgorithmics S.A.
Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. The company offers PocketECG, a diagnostic solution for the diagnosis of arrhythmia that provides disclosure ECG signal, complete data, analysis, and comprehensive reporting; and PocketECG CRS for cardiac rehabilitation monitoring. It also provides ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal; PatchECG, a device enabling single-channel offline monitoring; and PocketECG IV that enables the PocketECG to be connected over the LTE band for continuous ECG signal transmission. In addition, the company offers information technology, biotechnology, ECG monitoring, and scientific research and development services; and manufactures and sells electro-medical equipment. Medicalgorithmics S.A. was founded in 2005 and is headquartered in Warsaw, Poland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.10M | 62.72M | 120.56M | 111.73M | 173.87M | 199.40M | 203.35M | 127.92M | 49.33M | 29.71M | 15.70M | 10.96M | 5.80M | 4.11M |
| Cost of Revenue | 26.15M | 12.35M | 7.39M | 8.54M | 8.30M | 9.09M | 6.25M | 3.33M | 5.18M | 7.25M | 697.20K | 821.68K | 392.94K | 730.63K |
| Gross Profit | 16.95M | 50.37M | 113.17M | 103.19M | 165.57M | 190.32M | 197.10M | 124.59M | 44.15M | 22.46M | 15.00M | 10.14M | 5.41M | 3.38M |
| Gross Profit Ratio | 39.34% | 80.30% | 93.87% | 92.36% | 95.22% | 95.44% | 96.93% | 97.40% | 89.49% | 75.60% | 95.56% | 92.50% | 93.23% | 82.21% |
| Research & Development | 936.00K | 2.59M | 2.59M | 1.36M | 1.25M | 455.00K | 716.00K | 1.37M | 1.19M | 420.90K | 418.80K | 415.80K | 0.00 | 0.00 |
| General & Administrative | 13.35M | 5.02M | 31.07M | 28.61M | 30.52M | 23.48M | 21.92M | 35.19M | 12.19M | 1.98M | 1.58M | 1.40M | 105.24K | 29.56K |
| Selling & Marketing | 11.00K | 55.00K | 1.22M | 480.00K | 3.15M | 2.85M | 1.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 13.36M | 5.07M | 32.29M | 29.09M | 33.67M | 26.33M | 23.87M | 35.19M | 12.19M | 1.98M | 1.58M | 1.40M | 105.24K | 29.56K |
| Other Expenses | 2.22M | 29.25M | 85.28M | 108.50M | 131.56M | 138.49M | 131.63M | 42.96M | 10.83M | 6.59M | 3.41M | 1.67M | 2.22M | 1.23M |
| Operating Expenses | 16.52M | 34.32M | 117.57M | 137.59M | 165.23M | 164.82M | 155.50M | 78.15M | 23.02M | 8.57M | 4.99M | 3.07M | 2.32M | 1.26M |
| Cost & Expenses | 42.67M | 46.67M | 124.96M | 146.13M | 173.53M | 173.90M | 161.75M | 81.48M | 28.20M | 15.82M | 5.69M | 3.89M | 2.72M | 1.99M |
| Interest Income | 749.00K | 271.00K | 239.00K | 179.00K | 80.00K | 130.00K | 14.00K | 305.00K | 1.75M | 3.54M | 3.12M | 2.19M | 280.24K | 21.55K |
| Interest Expense | 105.00K | 271.00K | 888.00K | 958.00K | 2.08M | 3.51M | 4.11M | 3.29M | 23.50K | 2.50K | 800.00 | 100.13K | 6.02K | 15.11K |
| Depreciation & Amortization | 2.37M | 4.02M | 4.19M | 15.90M | 18.72M | 11.58M | 12.47M | 4.59M | 1.61M | 603.80K | 477.70K | 435.09K | 300.62K | 200.83K |
| EBITDA | 2.24M | 21.20M | -2.20M | -23.04M | 18.38M | 37.02M | 53.55M | 52.49M | 18.92M | 18.61M | 13.95M | 9.71M | 3.71M | 2.26M |
| EBITDA Ratio | 5.19% | 33.80% | -61.27% | -17.89% | 10.68% | 18.78% | 25.75% | 41.16% | 50.94% | 63.20% | 85.96% | 85.74% | 63.93% | 55.00% |
| Operating Income | 433.00K | 17.21M | -4.40M | -34.40M | -146.00K | 24.72M | 41.82M | 46.53M | 21.13M | 13.89M | 10.01M | 7.07M | 3.09M | 2.12M |
| Operating Income Ratio | 1.00% | 27.44% | -3.65% | -30.79% | -0.08% | 12.40% | 20.57% | 36.37% | 42.83% | 46.75% | 63.74% | 64.51% | 53.19% | 51.53% |
| Total Other Income/Expenses | -671.00K | 8.05M | 2.63M | -2.44M | -2.57M | -3.15M | -5.23M | -1.46M | -3.84M | 4.11M | 3.47M | 2.13M | 316.50K | -272.87K |
| Income Before Tax | -238.00K | 17.87M | -164.36M | -39.95M | -2.66M | 21.57M | 36.59M | 45.07M | 17.29M | 18.00M | 13.47M | 9.20M | 3.40M | 2.04M |
| Income Before Tax Ratio | -0.55% | 28.50% | -136.33% | -35.75% | -1.53% | 10.82% | 17.99% | 35.23% | 35.05% | 60.58% | 85.84% | 83.91% | 58.64% | 49.74% |
| Income Tax Expense | 340.00K | -216.00K | 16.28M | -12.27M | -2.36M | 2.63M | 2.94M | 3.07M | 3.36M | 3.47M | 2.60M | 1.76M | 398.39K | 133.00K |
| Net Income | -578.00K | 18.09M | -180.64M | -27.68M | -299.00K | 14.42M | 25.54M | 40.11M | 13.93M | 14.53M | 10.87M | 7.44M | 3.01M | 1.91M |
| Net Income Ratio | -1.34% | 28.84% | -149.83% | -24.77% | -0.17% | 7.23% | 12.56% | 31.35% | 28.23% | 48.89% | 69.27% | 67.86% | 51.78% | 46.50% |
| EPS | -0.11 | 3.17 | -39.73 | -6.69 | -0.08 | 4.00 | 7.08 | 11.12 | 3.86 | 4.22 | 3.18 | 2.60 | 1.21 | 0.22 |
| EPS Diluted | -0.06 | 3.17 | -39.73 | -6.69 | -0.08 | 4.00 | 7.08 | 11.12 | 3.86 | 4.22 | 3.18 | 2.60 | 1.21 | 0.22 |
| Weighted Avg Shares Out | 5.29M | 5.70M | 4.55M | 4.14M | 3.61M | 3.61M | 3.61M | 3.61M | 3.46M | 3.44M | 3.42M | 2.88M | 2.49M | 8.74M |
| Weighted Avg Shares Out (Dil) | 9.95M | 5.70M | 4.55M | 4.14M | 3.61M | 3.61M | 3.61M | 3.61M | 3.46M | 3.46M | 3.42M | 2.88M | 2.49M | 8.74M |
Source: https://incomestatements.info
Category: Stock Reports